Remove 2022 Remove Communication Remove HIPAA
article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

billion in a Series D funding round in April 2022. You may ask: Can an open protocol be HIPAA compliant? HIPAA does not specifically prohibit using and sharing open protocol-based software. Their patient journey typically requires engaging with discrete service providers, who are often using antiquated means of communication.

HIPAA 98
article thumbnail

How Pharmacists Can Manage Stress and Maximize Efficiency

Digital Pharmacist

Streamline patient communication on a secure platform that helps you send reminders, share images, and contact patients quickly and easily. With a HIPAA-compliant centralized platform, you can also view all patient conversations and send auto-populated messages. Secure 2-way messaging.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COVID-19, Flu, and RSV in 2023: What Pharmacists Should Know

Digital Pharmacist

Mandy Cohen, Director of the Centers for Disease Control and Prevention During 2022-2023, flu and RSV were part of a “tripledemic,” alongside COVID-19. Surges of RSV cases in the United States occurred much earlier than usual, starting in late fall 2022 instead of midwinter.

article thumbnail

Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies

pharmaphorum

This precipitated a shift from a centralised trial experience to a decentralised one, resulting in participants communicating electronically. billion smartphone users globally in 2022. Therefore, vendor applications must adhere to HIPAA and GDPR data protection regulations, including encryption and multifactor authentication.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

As noted in our previous communications, while the NHC would prefer a more traditional Notice and Comment rulemaking opportunity that would ensure the Agency directly responds to stakeholder feedback, we welcome this opportunity to express our reactions to CMS’ thinking on the negotiation program.

article thumbnail

NHC Comments on Interoperability and Prior Authorization Proposed Rule

Putting Patients First Blog

We urge CMS to be as specific as possible about what information must be included in a notice of denial and that it must be specific, complete, actionable, and communicated to patients in plain language. We support efforts to assure that patients and providers have access to clear and actionable information about denials.

HIPAA 40
article thumbnail

Understanding the current and future state of complex health data protection laws

Pharmaceutical Technology

Compliance in the US – HIPAA The Health Insurance Portability and Accountability Act (HIPAA) covers several areas relating to health data, with one of the key requirements being a set of standards – the Privacy Rule and the Security Rule – to protect sensitive PHI from being disclosed without the patient’s consent.